IP Library › Granted Patent US 11,051,516
Granted Patent B2
US 11,051,516 · App. 15/126,855 · Granted Jul 6, 2021

Antimicrobial sanitizer compositions and their use

Inventors: Paul Geoffrey Smyth (Murarrie, AU); Michael Paul Bralkowski (Lexington, NC)
Assignee: Global Bioprotect IP Pty Ltd
A01N55/00A01N33/12A01N47/44A61K8/39A61K8/416A61K8/604A61K8/84A61K8/893A61K31/695A61Q17/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,051,516
App. No.
15/126,855
Granted
Jul 6, 2021
Kind
B2
Abstract

The present invention relates to antimicrobial sanitizing compositions for use as skin sanitizers, especially sanitizers for the hands and feet, and air sanitizers and deodorisers. The sanitizing compositions comprise a combination of three ammonium compounds (ie. an alkoxy silyl ammonium compound, a benzalknonium chloride or benzethonium chloride and a polymeric biguanide) in a non-ionic surfactant carrier. The non-ionic surfactant system comprises an alcohol ethoxylate and an alkylglucoside or alkylpolyglycoside. Methods of use of the compositions are also described.

Claims (26)

1. A sanitizing composition comprising:

i) 0.1% to 1.5% w/w of an alkoxy silyl ammonium film-forming compound;

ii) 0.1% to 1.0% w/w of a benzalkonium or benzethonium chloride;

iii) 0.1% to 1.5% w/w of a polymeric biguanide;

iv) a surfactant system comprising:

a. 0.1% to 1% w/w of an alcohol ethoxylate; and

b. 0.1% to 0.5% w/w of an alkylglucoside or alkylpolyglycoside; and

v) an aqueous carrier;

wherein said composition comprises no ethyl alcohol;

wherein said composition is effective in sanitizing human skin surface;

wherein said composition provides >10 6 /mL reduction of Staphylococcus aureus (ATCC 6538) within 60 seconds as measured under ASTM 2315-03;

wherein the pH of the composition is about 5.5; and

wherein the composition comprises glycerin.

2. The sanitizing composition according to claim 1 wherein the alkoxy silyl ammonium film-forming compound is selected from 3-trimethoxysilylpropyl-N,N-dimethyl-N-octadecyl ammonium chloride, 3-triethoxysilylpropyl-N,N-dimethyl-N-octadecyl ammonium chloride, 3-triethoxysilylpropyl-N,N-dimethyl-N-isodecyl ammonium chloride and 3-trimethoxysilylpropyl-N,N-dimethyl-N-isodecyl ammonium chloride.

3. The sanitizing composition according to claim 1 wherein the polymeric biguanide is a polyaminopropyl biguanide or polyhexamethylene biguanide.

4. The sanitizing composition according to claim 1 wherein the polymeric biguanide is present in an amount of 0.1% to 1.0% w/w of the composition.

5. The sanitizing composition according to claim 1 wherein the alcohol ethoxylate surfactant is a C12-18 alcohol ethoxylate comprising 6 to 16 moles of ethylene oxide.

6. The sanitizing composition according to claim 1 wherein the alkylglucoside surfactant is caprylyl glucoside.

7. The sanitizing composition according to claim 1 further comprising a dye or an extract of aloe vera.

8. The sanitizing composition of claim 1 , wherein said composition provides a persistent antibacterial efficacy to porcine skin pads against methicillin-resistant Staphylococcus aureus (MRSA) strain ATCC 33592 at 5 hours after the composition is applied to the skin pads; said persistent antibacterial efficacy providing greater than a 5.8 log 10 reduction in methicillin-resistant bacterial growth compared to porcine skin pads treated in the same manner without application of the sanitizer composition.

9. The sanitizing composition according to claim 1 in the form of a liquid.

10. The sanitizing composition according to claim 1 in the form of a gel.

11. A method of sanitizing or disinfecting skin comprising applying to the skin, the sanitizing composition of claim 1 .

12. A method according to claim 11 wherein the skin is the skin of hands or feet.

13. A method of treating a fungal infection of the skin, comprising applying the sanitizing composition according to claim 1 to the skin of a subject.

14. A method according to claim 13 wherein the fungal infection is a Tinea infection.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 19, 2021
From: SMYTH, PAUL GEOFFREY; BRALKOWSKI, MICHAEL PAUL
To: GFS CORPORATION AUS PTY LTD
Reel/Frame 055340/0482 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 25, 2018
From: GLOBAL BIOPROTECT PTY LTD
To: GLOBAL BIOPROTECT IP PTY LTD
Reel/Frame 045906/0995 →
CONFIRMATORY ASSIGNMENT Recorded May 25, 2018
From: GFS CORPORATION AUS PTY LTD
To: GLOBAL BIOPROTECT PTY LTD
Reel/Frame 046245/0643 →
Priority Claims (1)
AU 2014900900 · Mar 17, 2014 · national
Continuity (1)
Related Publication 20170094974A1 · Apr 6, 2017